JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vosoughian, M.
Right arrow Articles by Maftuh, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vosoughian, M.
Right arrow Articles by Maftuh, H.
Related Collections
Right arrow Regional Anesthesia
Right arrow Pharmacology

Anesth Analg 2007;105:531-533
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000268496.46141.4f


ANALGESIA

The Duration of Spinal Anesthesia with 5% Lidocaine in Chronic Opium Abusers Compared with Nonabusers

Maryam Vosoughian, MD*, Ali Dabbagh, MD*, Samira Rajaei, MD{dagger}, and Hassan Maftuh, MD*

From the *Department of Anesthesiology, Faculty of Medicine, Shaheed Beheshti University; and {dagger}Department of Immunology, Faculty of Medicine, Tehran University, Tehran, Iran.

Address correspondence and reprint requests to Ali Dabbagh, MD, Fellowship in Cardiac Anesthesia, Department of Anesthesiology, Taleghani Hospital, Velenjak, Chamran Exp Way, Tehran, Iran. Address e-mail to alidabbagh{at}yahoo.com.

Abstract

BACKGROUND: It has been demonstrated that chronic opium abusers have lower thresholds for pain. In this study we sought to determine whether chronic opium abuse has any effect on the duration of spinal block by local anesthetics.

METHODS: In a case-controlled study, 50 opium abusers and 50 nonabusers undergoing lower abdomen operations were selected from among the patients admitted to a university hospital for elective surgery. All patients received 100 mg hyperbaric preservative-free 5% lidocaine in dextrose, intrathecally.

RESULTS: The duration of anesthesia was much shorter in the opium abusers (60 ± 7 min) than in the nonabusers (83 ± 10 min) (P < 0.0001).

CONCLUSION: The study documents a shortened duration of spinal block in opium abusers.

The opioid analgesics, exemplified by morphine, are a common treatment of severe acute and chronic (both malignant and nonmalignant) pain states (1). Prolonged use of opioids is associated with progressive need for higher doses to achieve a constant analgesic effect, a phenomenon well known as analgesic tolerance. The exact mechanisms which underlie this phenomenon remain unclear (1–3), although a number of hypotheses have been proposed regarding the opioid receptors and the endogenous opioid peptides (4–7). New insights into pain and its regulation in opium abusers have been introduced (8–11). For instance, we have observed a shorter than expected duration of spinal anesthesia using intrathecal lidocaine for opium abusers. This clinical phenomenon could be linked to a number of previously observed conditions attributed to opioid tolerance (1,3,12–15).

This clinical study was planned to compare the duration of effect of intrathecal lidocaine in opium abuser and nonabuser patients undergoing similar surgical operations.

METHODS

This study met IRB requirements for human and animal trials and conformed to the criteria of the Ethics Committee, Department of Research Affairs, Faculty of Medicine, Shaheed Beheshti University of Medicine, Tehran, Iran. All patients gave written informed consent to participate in the trial.

In a descriptive-analytical, case–control, prospective study, the target population was all surgical patients being admitted to the hospital’s operating room, which was the study location, during a 6-mo period. One hundred patients (age 15–65 years and height 150–185 cm) scheduled for elective lower abdominal surgery were allocated into two groups according to their history of opium addiction. The opium group comprised chronic opium abusers, regularly using opium preparations orally or by inhalation, for at least 1 yr, all of whom described subjective symptoms of withdrawal from drug cessation. Patients in the control group, by self-report, had not used opium for the preceding 2 yr. Exclusion criteria were: patient refusal of subarachnoid block, abuse or illicit use of other controlled substances, preexisting cardiac or pulmonary disease, or any sign or clinical finding, denoting past or present neuropathy.

All patients were visited the night before surgery by the same anesthesiologist (one of the authors), and were informed about the study. A premedication dose of promethazine was also prescribed for 0.05 mg/kg IM administration 1 h before the surgery, accompanied by a 10 mg diazepam tablet per 70 kg body weight. In the case of chronic opium abuse, patients were told to use their usual daily dose; this was discussed in a private room with each opium abuser and the anesthesiologist who had visited the patient the evening before surgery. All patients were NPO for 8 h before the scheduled surgical procedure.

The anesthesiologist who performed the subarachnoid block and documented the sensory level was blinded to the patient’s history of opium abuse. After initiating standard monitoring (electrocardiogram, pulse oxymetry, noninvasive arterial blood pressure, and heart rate), the patients received 500–750 mL of lactated Ringer’s solution over 15–20 min. Subarachnoid blocks were performed with the patient in the sitting position under appropriate aseptic conditions. The L3–4 interspace was entered and a 24-gauge Whitacare spinal needle was inserted via a midline approach. The needle bevel was oriented cephalad while 100 mg of 5% preservative-free hyperbaric lidocaine with dextrose was injected at a rate of 2 mL every 5 s. The patients were placed supine after drug injection. All patients received 1 mg IV midazolam for sedation after spinal administration of the drug and a T6–T8 level of anesthesia was achieved with the help of position maneuvers. Sensory level was assessed with pinprick each minute thereafter for 10 min. The level of anesthesia was then checked and documented in 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, and 120 min after subarachnoid drug administration. If any patient had pain at any time during the operation, general anesthesia was induced immediately and the subarachnoid effects of the local anesthetic drug (spinal anesthesia) were considered to be terminated and, the final time of spinal anesthesia was recorded. The total time for effective spinal anesthesia was recorded from the drug injection time (as the start point) up to the time that a two-segment regression in the level of block (using a pinprick test) was detected.

Data entry and analysis were performed by S.P.S.S software (version 11.5). For data analysis, Student’s t-test and {chi}2 test were used as the statistical tests and a P value <0.05 was considered significant.

RESULTS

The two groups had no significant differences in respect to age, body weight, gender, or surgical duration (Table 1). In the opium abusers, the duration of opium abuse was 6.2 ± 1.8 yr. The most common pattern of abuse was inhalation (79.6% i.e., 39 patients among the abusers); the others (20.4%, i.e., 11 patients) abused opium orally. All the abusers used opium habitually and not as a prescribed drug. The average time interval between events of opium abuse in the abusers’ group was 30 ± 38 h.


View this table:
[in this window]
[in a new window]

 
Table 1. Distribution of Age, Body Weight, Duration of Surgery, and Sex{dagger} in the Two Groups

 

The duration of spinal anesthesia was significantly shorter in the abuser group (60 ± 7 min) than the nonabuser group (83 ± 10 min) (P < 0.0001).

Two patients among the nonabusers and three patients among the abusers had failed spinal anesthesia. They were excluded from the study and replaced by other qualified patients.

DISCUSSION

Factors affecting duration of block in spinal anesthesia include the type of local anesthetic, drug dosage and drug adjuvants such as opioids and epinephrine, among others (16). This study, however, demonstrated shortened duration of subarachnoid block in those patients who with a history of chronic opium abuse, a variable that has not previously been studied.

Although there was some difficulty in asking about a history of opium abuse, this was somewhat compensated for when the anesthesiologist was open and friendly the patients. Also, had it been possible to obtain objective documentation of opium abuse without ethical considerations, more precise data regarding the abuse may have resulted; however, this was not possible and only subjective assessments were considered. Likewise, it was difficult to assess the exact dose and time intervals of opium abuse. One of the other limitations of the study was that we did not assess motor block after intrathecal anesthesia, because of surgical limitations.

Administration of opioids typically results in analgesia. However, the opioid receptor system signals and modulates a multitude of effects and, under certain conditions, mediates hyperalgesia rather than analgesia (17). Many studies have tried to define the exact mechanisms creating opioid-induced hyperalgesia. Recent research suggests that opioid-induced hyperalgesia is complex, and involves multiple potential areas of pain amplification, including descending tonic facilitation originating in the rostral ventromedial medulla, the release of pronociceptive spinal dynorphin, and the potential interaction of excitatory amino acid neurotransmitters with other receptor systems. It is unclear whether these pain facilitating processes play a collective role in a phenomenon that mimics local anesthetic tolerance, whether there is some sort of cross-tolerance of local anesthetics with opioids, or whether other factors, e.g., voltage-gated sodium channel effects are involved. In addition to the classic opioid receptors a number of other receptors are affected by opioids both in the central and the peripheral nervous system (4–7,14,18) and, a number of studies have proposed some structural similarities between opioid and local anesthetic receptors in the spinal cord (9,10,19).

Future investigation is required to explain the clinical finding of shorter duration of intrathecal local anesthetic block in a variety of patients, especially those with altered pharmacokinetics (e.g., opium abusers). Further investigation may also help augment our understanding about transduction and the processing mechanisms of pain in the central nervous system (17).

The findings of this study suggest a shorter duration of neural block, after induction of spinal anesthesia with intrathecal administration of lidocaine, in chronic opium abusers compared with other, similar patients who are not abusing opium. This may be useful in selecting a local anesthetic drug and dose and the addition of adjuncts to prolong spinal blockade.

ACKNOWLEDGMENTS

The authors thank the administrative support of Department of Research Affairs, Faculty of Medicine, Shaheed Beheshti University of Medicine, Tehran, Iran in the course of the project. The authors also acknowledge the very kind help of Mrs. Soheila Moezzipur as the administrative coordinator of the study. And finally, the operating room authorities of Taleghani Hospital, Shaheed Beheshti University of Medicine, Tehran, Iran are highly appreciated, who handled the patients through their operation.

Footnotes

Accepted for publication April 10, 2007.

This study was performed as a research project in the Department of Anesthesiology, Taleghani Hospital, Faculty of Medicine, Shaheed Beheshti University, Tehran, Iran.

REFERENCES

  1. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005;80:319–24[ISI][Medline]
  2. Gardell LR, King T, Ossipov MH, Rice KC, Lai J, Vanderah TW, Porreca F. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett 2006;396:44–9[ISI][Medline]
  3. Ossipov MH, Lai J, King T, Vanderah TW, Malan TP Jr, Hruby VJ, Porreca F. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004;61:126–48[ISI][Medline]
  4. Szeto HH, Soong Y, Wu D, Qian X, Zhao GM. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA. J Pharmacol Exp Ther 2003;305:696–702[Abstract/Free Full Text]
  5. Christie MJ, Williams JT, North RA. Cellular mechanisms of opioid tolerance: studies in simple brain neurons. Mol Pharmacol 1987;32:633–4[Abstract]
  6. Bovill JC. Mechanisms of action of opioids and non-steroidal anti-inflammatory drugs. Eur J Anaesthesiol Suppl 1997;14:9[Medline]
  7. Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord. J Pharmacol Exp Ther 2004;310:240–6[Abstract/Free Full Text]
  8. Chen SR, Pan HL. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 2003;99:1409–14[ISI][Medline]
  9. Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, Eschalier A. Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 2003;307:268–74[Abstract/Free Full Text]
  10. Hurley RW, Banfor P, Hammond DL. Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat. Neuroscience 2003;118:789–96[ISI][Medline]
  11. Yoburn BC, Gomes BA, Rajashekara V, Patel C, Patel M. Role of G(i) alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo. Synapse 2003;47:109–16[ISI][Medline]
  12. Vanderah TW, Suenaga NM, Ossipov MH, Malan TP Jr, Lai J, Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 2001;21:279–86[Abstract/Free Full Text]
  13. Xie JY, Herman DS, Stiller CO, Gardell LR, Ossipov MH, Lai J, Porreca F, Vanderah TW. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005;25:409–16[Abstract/Free Full Text]
  14. Allen RM, Dykstra LA. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Psychopharmacology (Berl) 1999;142:209–14[Medline]
  15. King T, Gardell LR, Wang R, Vardanyan A, Ossipov MH, Malan TP Jr, Vanderah TW, Hunt P, Hruby VJ, Lai J, Porreca F. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain 2005;116:276–88[ISI][Medline]
  16. Brown DL. Spinal, epidural, and caudal anesthesia. In: Miller RD, ed. Miller’s anesthesia. 6th ed. Philadelphia: Elsevier, Churchill Livingstone Inc, 2005:1653–84
  17. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006;104:570–87[ISI][Medline]
  18. Laulin JP, Maurette P, Corcuff JB, Rivat C, Chauvin M, Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 2002;94:1263–9[Abstract/Free Full Text]
  19. Modalen AO, Westman L, Arlander E, Eriksson LI, Lindahl SG. Hypercarbic and hypoxic ventilatory responses after intrathecal administration of bupivacaine and sameridine. Anesth Analg 2003;96:570–5[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vosoughian, M.
Right arrow Articles by Maftuh, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vosoughian, M.
Right arrow Articles by Maftuh, H.
Related Collections
Right arrow Regional Anesthesia
Right arrow Pharmacology


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press